Felicitex Therapeutics Inc. (FLCT)

Felicitex Therapeutics will go public soon, but the exact IPO date is still unknown.

IPO Price

$6.25

Shares Offered

2,480,000

Deal Size

$15.50M

Felicitex Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-1.76	-1.35	-0.72
Depreciation & Amortization	0	0	0.14
Share-Based Compensation	-	0.34	-
Other Operating Activities	0.62	0.12	-0.4
Operating Cash Flow	-1.15	-0.89	-0.98
Capital Expenditures	0	-	-0
Investing Cash Flow	0	-	-0
Debt Issued / Paid	-	0.59	0.38
Other Financing Activities	1.17	0.27	0.63
Financing Cash Flow	1.17	0.86	1.01
Net Cash Flow	0.02	-0.03	0.03
Free Cash Flow	-1.15	-0.89	-0.98

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).